Meta analysis of the clinical effect of sulfasalazine combined with probiotics on the treatment of inflammatory bowel disease
10.3760/cma.j.issn.1008-1372.2019.06.012
- VernacularTitle:柳氮磺吡啶联合益生菌治疗炎症性肠病临床效果的Meta分析
- Author:
Zhen WANG
1
;
Xiaoli YANG
;
Lili ZHU
;
Jing XUE
;
Ke LI
;
Hao WANG
;
Shaoqi YANG
Author Information
1. 宁夏医科大学临床医学院
- Keywords:
Sulfasalazine;
Probiotics;
Inflammatory bowel diseases;
Colitis,ulcerative;
Meta-analysis
- From:
Journal of Chinese Physician
2019;21(6):850-855
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficacy of domestic sulfasalazine (SASP) combined with probiotics on the treatment of inflammatory bowel disease (IBD).Methods According to the search of Chinese periodical full-text database,PubMed and other Chinese databases as well as English databases,the cases of IBD treated with SASP combined with probiotics or metronidazole in China were collected and screened for randomized controlled trials (RCT).The results between combined group and control group were compared using odds ratio (OR) and 95％ Confidence Interval (CI) indicates.The evaluation indicator was the remission rate.According to the inclusion and exclusion criteria,the literature was selected,and data was extracted.Quality assessment of the included methodologies was performed,and RevMan 5.3 software was used for meta-analysis.Results 26 studies including a total of 2 403 patients were adopted in the present study.Among them,13 studies suggested that the remission rate of IBD in SASP combined with probiotics group was significantly improved compared with that in the SASP group alone (x2 =10.29,df =12,I2 =0％,P ＜0.05,the effect model OR =3.70,95％ CI as 2.62-5.21),demonstrating that the combined treatment was superior to monotherapy in IBD.10 studies suggested that the remission rate of ulcerative colitis (UC) in SASP combined with probiotics group was significantly improved compared with that in the SASP group alone (x2 =2.59,df =9,I2 =0％,P ＜ 0.05,the effect model OR =3.84,95％ CI as 2.52 -5.86),demonstrating that the combined treatment was superior in UC.The other 3 studies showed that the remission rate of UC with infection in SASP combined with probiotics group was significantly improved compared with that in SASP combined with metronidazole group (x2 =0.07,df =2,I2 =0％,P ＜ 0.05,the effect model x2 =4.77,95％ CI as 2.27-10.02),demonstrating that treatment of SASP combined with probiotics was superior in UC with infection.Conclusions SASP combined with probiotics can improve the effective response rate in the treatment of IBD.
